Physician profile
Stephen C Smith
NPI 1275025041
$2,506.04
in general payments reported to CMS, 2019-2025
14 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $301 · 2023: $1,011 · 2024: $578 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,501 · Travel and Lodging: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,500.66 |
| Travel and Lodging | $561.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $913.81 | 2022-2024 | |
| Smith+Nephew, INC. | $293.23 | 2022-2023 | Grafix Xc, Grafix Pl, Stravix Pl |
| Amgen INC. | $249.98 | 2025 | Krystexxa |
| Medtronic, INC. | $154.50 | 2025 | Inceptiv |
| Next Science LLC | $153.88 | 2024 | Surgx, Blastx, Xperience |
| Paratek Pharmaceuticals, INC. | $142.11 | 2022-2024 | Nuzyra |
| Horizon Therapeutics Plc | $134.17 | 2022-2023 | Krystexxa |
| Stryker Corporation | $130.59 | 2024 | Allowrap, 7 X 23mm Citrelock Implant, Augment Injectable |
| Kerecis Limited | $83.64 | 2021-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Pacira Pharmaceuticals Incorporated | $67.61 | 2021 | |
| Advanced Oxygen Therapy INC. | $66.92 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Alfasigma USA, INC. | $64.75 | 2021-2022 | |
| Averitas Pharma INC. | $29.06 | 2024 | Qutenza |
| Abbott Laboratories | $21.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.